
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab
Νam H et al.Hepatology (Baltimore, Md.), 30 Jun 2025, https://doi.org/10.1097/hep.0000000000001444 Πατήστε ΕΔΩ για να δείτε την περίληψη του άρθρου








